Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
6,752,518
-
Shares change
-
+695,119
-
Total reported value, excl. options
-
$100,597,635
-
Value change
-
+$11,330,602
-
Put/Call ratio
-
83%
-
Number of buys
-
37
-
Number of sells
-
-15
-
Price
-
$14.9
Significant Holders of PDS Biotechnology Corp - Common (PDSB) as of Q3 2021
68 filings reported holding PDSB - PDS Biotechnology Corp - Common as of Q3 2021.
PDS Biotechnology Corp - Common (PDSB) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,752,518 shares
of 49,594,356 outstanding shares and own 13.62% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (977,702 shares), AIGH Capital Management LLC (773,560 shares), TWO SIGMA ADVISERS, LP (478,400 shares), BlackRock Inc. (429,178 shares), TWO SIGMA INVESTMENTS, LP (380,742 shares), RENAISSANCE TECHNOLOGIES LLC (365,837 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (335,378 shares), Invesco Ltd. (329,698 shares), EAM Investors, LLC (258,769 shares), and INSPIRION WEALTH ADVISORS, LLC (253,877 shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.